Begins Coverage on Organovo (NASDAQ:ONVO) initiated coverage on shares of Organovo (NASDAQ:ONVOFree Report) in a research report released on Monday morning. The firm issued a sell rating on the medical research company’s stock.

Organovo Stock Up 1.0 %

ONVO stock opened at $1.04 on Monday. Organovo has a 52 week low of $0.85 and a 52 week high of $2.05. The stock has a market capitalization of $10.44 million, a P/E ratio of -0.48 and a beta of 0.87. The firm has a 50-day simple moving average of $1.03 and a 200-day simple moving average of $1.09.

About Organovo

(Get Free Report)

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.

Recommended Stories

Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with's FREE daily email newsletter.